Press Releases May 1, 2026 08:15 AM

Oportun Named to USA Today’s America’s Best Customer Service in Financial Services List 2026

Oportun Honored by USA Today for Outstanding Customer Service in Financial Services for 2026

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
OPRT

Oportun, a Nasdaq-listed financial services company, has been recognized by USA Today as one of America's Best Customer Service providers in Financial Services for 2026. This recognition highlights Oportun's commitment to exceptional customer care and its mission to assist members in building a better financial future through intelligent borrowing, savings, and budgeting tools.

Oportun Named to USA Today’s America’s Best Customer Service in Financial Services List 2026
OPRT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Oportun recognized among top 500 financial service companies for customer service based on feedback from over 31,000 U.S. consumers.
  • Award underscores Oportun's core mission of providing responsible, affordable credit and financial empowerment to members.
  • The company has facilitated over $21.3 billion in credit, saving members over $2.5 billion in fees and interest, reflecting strong member support and value delivery.

SAN MATEO, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- Oportun (Nasdaq: OPRT), a mission-driven financial services company, announced that it has been honored by USA Today as one of America’s Best Customer Service in Financial Services of 2026. Oportun was recognized for the exceptional customer service it provides to members in support of its intelligent borrowing, savings, and budgeting tools.

This prestigious award is based on a comprehensive evaluation conducted by USA Today and Plant-A Insights Group, combining feedback from more than 31,000 U.S. consumers with independent research. Customers shared their real experiences with financial service providers, rating what matters most, like professionalism, transparency, and how well companies meet their needs. Only the top 500 best-performing companies earned a place on the final list.

“At Oportun, great service is core to our mission to help members build a better financial future,” said Ryan Helwig, Chief Operations Officer. “Being recognized by USA Today as one of the nation’s best in customer service in financial services is a well-deserved recognition for our entire team and reflects the care and commitment we bring to every member interaction.”
For more information about Oportun, visit https://oportun.com.

About Oportun
Oportun (Nasdaq: OPRT) is a mission-driven financial services company that puts its members' financial goals within reach. With intelligent borrowing, savings, and budgeting capabilities, Oportun empowers members with the confidence to build a better financial future. Since inception, Oportun has provided more than $21.3 billion in responsible and affordable credit, saved its members more than $2.5 billion in interest and fees, and helped its members save an average of more than $1,800 annually. For more information, visit Oportun.com.


Risks

  • Recognition depends on consumer perception which could fluctuate, potentially affecting future customer sentiment and company reputation.
  • Competition in the financial services sector may challenge Oportun's ability to maintain its leadership in customer service and member satisfaction.
  • Economic downturns could impact the borrowing capacity and creditworthiness of Oportun's member base, affecting company financials.

More from Press Releases

Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control Jun 14, 2026 Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026 Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026